×
Please click
here
if you are not redirected within a few seconds.
All
News
Maps
Images
Videos
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
enVVeno Medical's VenoValve proves effective in study
Medical Device Network
The VenoValve is a first-in-class surgical replacement venous valve being developed for the treatment of deep venous chronic venous...
1 month ago
enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update
AccessWire
Ended the quarter with $42.9 million cash and investments on hand sufficient to fund current operations, including multiple value driving...
4 weeks ago
enVVeno Medical Corporation's (NASDAQ:NVNO) Path To Profitability
Yahoo Finance
According to some industry analysts covering enVVeno Medical, breakeven is near. They expect the company to post a final loss in 2025, before...
4 months ago
enVVeno Medical Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
Kansas City Star
enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous...
3 months ago
enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the ...
BioSpace
enVVeno Medical Presents Positive Preliminary Device Related Material Adverse Event (MAE) Data from the VenoValve Pivotal Trial at the 50th...
6 months ago
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual ...
Sacramento Bee
enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous...
1 month ago
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve ...
Miami Herald
enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous...
1 month ago
enVVeno: The Road To Approval Seems Open From Here On (NASDAQ:NVNO)
Seeking Alpha
enVVeno Medical Corporation has released remarkably positive topline data from its pivotal trial for the VenoValve. The path to file for...
2 months ago
Analyzing enVVeno Medical (NASDAQ:NVNO) & Vivos (OTCMKTS:RDGL)
Defense World
Read Analyzing enVVeno Medical (NASDAQ:NVNO) & Vivos (OTCMKTS:RDGL) at Defense World.
2 weeks ago
Positive Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal ...
Charlotte Observer
97% of VenoValve Study Patients Showing Clinical Improvement at Six Months (as Measured by the Revised Venous Clinical Severity Score...
2 months ago